Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-021-02688-5
Abstract: Cyclin-dependent kinases (CDKs) play a key regulating role in the cell cycle, which is almost universally altered in cancer, leading to sustained proliferation. Early pan-CDK inhibitors showed poor results in clinical trials for solid malignancies,… read more here.
Keywords: cdk inhibitors; solid tumors; cyclin dependent; inhibitors solid ... See more keywords